1. Market Research
  2. > Healthcare Market Trends

Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)

  • May 2015
  • Firstword Pharma
Report ID: 3090969

Summary

Table of Contents




Gain exclusive insights on the perceived value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists.

Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US) is based on survey results from 50 US oncologists (33 medical oncologists and 17 haematologist-oncologists) and offers insights on what oncologists believe are the critical issues, challenges and opportunities within the personalised medicines space, and how oncologists intend to adopt personalised medicine in the future.








Quantitative Analysis

A great deal of anticipation and expectation surrounds personalised medicine. While there have been some notable successes, the promise of personalised medicine – right medicine, right patient, right time – has failed to materialise in many disease areas where a personalised approach could drive better patient outcomes. Concerns amongst key stakeholder groups remain, particularly in relation to development, access and implementation of personalised healthcare strategies.

This survey provides US physician insights into personalised medicine within the oncology setting. By understanding what oncologists in the US think about the key challenges, opportunities and concerns, companies operating in the oncology market and seeking to leverage personalised medicine for their products can gain a deep understanding of what’s needed to drive long-term commercial success.



Gain Answers to Key Questions

How do US physicians rank perceived application values of personalised medicine?
How do US physicians rank the top potential benefits of personalised medicine for physicians and patients?
What are US physician insights on the current usage of personalised medicine for the treatment of all cancer types, including solid and blood tumours?
How do US physicians rank access and data challenges?
If access and data challenges were minimal – what proportion of US physicians would prescribe personalised medicines?
What critical factors do US physicians think enable effective current and future usage of personalised medicine?




Report Features
Filled with charts and up-to-the-minute survey analysis, this report offers:

Precise and timely analysis of US oncologist awareness, perception of value, promise and benefits of personalised medicine
Data and insight on current usage and access status, and challenges related to personalised medicine access and adoption intention
US Oncologist views on the critical enablers and success factors of personalised medicine, as well as anticipated future developments



About the Survey
Interview Methodology
Data was collected via a 10-minute internet-based questionnaire

Sample
US: 50 oncologists (33 medical oncologists and 17 haematologist-oncologists).

Screening Criteria
Respondents were screened to ensure that they see at least 100 patients in total in a typical month, have been in active practice between 3-35 years, devote at least 50% of time to direct patient care and are aware of personalised medicine


Top Takeaways

Insight on US oncologist awareness of personalised medicine, their impact on patient care and the value of personalised medicines overall clinical outcomes
Views on the critical benefits of personalised medicine, and key issues related to how personalised medicine can support access to innovative therapies
Opinions on the future use of personalised medicine, and what key barriers are likely to slow adoption rates




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence./Paragraph>



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

North America Biopsy Devices Market Outlook to 2023

  • $ 5995
  • Industry report
  • May 2017
  • by GlobalData

North America Biopsy Devices Market Outlook to 2023 Summary GlobalData’s new report, "North America Biopsy Devices Market Outlook to 2023", provides key market data on the North America Biopsy Devices ...

EU5 Aesthetic Lasers and Energy Devices Market Outlook to 2023

  • $ 5995
  • Industry report
  • May 2017
  • by GlobalData

EU5 Aesthetic Lasers and Energy Devices Market Outlook to 2023 Summary GlobalData’s new report, "EU5 Aesthetic Lasers and Energy Devices Market Outlook to 2023", provides key market data on the EU5 Aesthetic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.